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tertiary center between 19962001. 
Results Three percent @O/3045) of patients with ACS developed or had concurrent clin- 
ically significant GIB. In-hosptial mortality was significantly higher in patients with versus 
without GIB (36% vs. 5%, pcO.001). Thirty-patients underwent endoscopy during the 
index hospitalization with no associated complications of death, arrhythmia, urgent 
ischemia, or hemodynamic deterioration. Definitive GI diagnosis from endoscopy are 
shown in the table below. 
1145-104 Green lea Inhibits Stat-l Activation and Reduces 
Apoptosis in Cardiac Myocytes Exposed to lschemial 
Reperfusion Injury 
vSteDhanou, Tiziano M. Scarabelk, Kevin Lawrence, Paul Townsend, Carol 
ChewScarabelk, Richard Knight, David Latchman, Institute of Child Health, University 
College London, London, United Kingdom 
Background. We have reported previously that the transcription factor STAT-l is acti- 
vated following l/R and is also a mediator of apoptotic cell death in cardiac myocyies. 
Recently green tea (GT) has been shown to have antioxidant properties and also to 
reduce the expression of STAT-l in non-cardiac cells. In the present study, we have 
assessed the role of GT as a cardioprotective agent in cultured cardiac myocytes 
exposed to simulated I/R. 
Methods. Primary rat neonatal cardiomyocytes were pretreated with GT (5Cugiml) and 
either left under normoxic condition or exposed to simulated l/R by in an ischemic cham- 
ber for 4 hours followed by16 hrs or reoxygenation to simulate reperfusion. Western blot- 
tina and immunoflouresence studies were oerformed with soecific ohosoho-antibodies 
against STAT1 Tyr701 and STAT1 Ser727. Results. Cardiac myocytes pretreated with 
GT reduced the level of aooototic cell death followino simulated I/R iniurv from 37% (I/R) 
,  I  I  I  
lo 17 % (GT plus I/R). Western blot analysis demonstrated that GT also reduced the lev- 
els of phosphorylated STATIJOI and STATl-727 in cardiac myocytes exposed to simu- 
lated l/R. lmmunoflouresence assessment confirmed that GT also abrogated nuclear 
translocation of activated STATl-701 and STATl-727 in cardiac myocytes exposed to 
simulated I/R. Finally treatment with GT also reduced the expression of FASL and FAS 
receptor in cardiac myocytes. 
Conclusions. Our data demonstrates that GT is able to protect cardiac myocytes from 
apoptosis following simulated l/R injury, whrch may in part be acting by preventing the 
activation and nuclear translocation of STAT-l. Hence, GT may have a therapeutic role 
in modulating pro-apoptotic STAT-l target genes. 
1145-105 Bag-l Relocates Within Cardiac Myocytes Following 
Ischemia/Reperfusion and Prevents Myocyte Apoptosis 
by Interaction With Hsc70 
Paul Townsend, Tiziano M. Scarabelk, Kevin Lawrence, Anastasis Stephanou, 
Christopher Carroll, Carol ChewScarabelli, Ramsey C&tress, Graham Packham, David 
Latchman, Institute of Child Health, Unwersity College London, London, United Kingdom 
Background. BAG-l is a family of proteins, which promotes cell survival and modulates 
chaperone activity by interacting with a wide range of cellular targets. Here we examined 
the level of protein expression and the subcellular distribution of BAG-l both in cultured 
myocytes and the isolated rat heart. as well as its potential cardioprotective role during 
ischaemia(l)lreperfusion(R) injury.Methods and Results By immunocytochemistry, in 
tissue sections from control hearts, BAG-1 positive staining was seen in the nuclei of the 
majority of myocytes (57+/-6.3%). In only 2.4+/-0.5% of control myocytes cytoplasmic 
staining was observed. Conversely, in rat hearts exposed to 35 mins I and 120 mins R, 
nuclear staining for BAG-l was reduced (lo+/-2.3 %) with a corresponding increase in 
the number of myocytes exhibiting cytosolic localisatlon (26+1-4.7%; p<O.OOl vs control). 
Since western blot analysis of rat hearts exposed to I/R did not detect any BAG-l induc- 
tion, the above finding suggest that BAG-l can actively relocate from the nuclei to the 
cytoplasm upon I/R. Similar results were obtained by western blotting analysis of subcel- 
lular fractions from cultured myocytes and the intact heart. Overexpression of human 
BAG-l in primary cultures of neonatal cardiac myocytes, exposed to 4 hours of simulated 
I followed by 16 hours of R, significantly reduced the percentage of TUNEL positive myo- 
cytes from 37+/-5.1% to 21+/-4.3% (p<O.OOl). Moreover, in both cultured myocytes and 
the intact heart following I/R. BAG-l co-rmmunoprecipitated with HSC70. Finally, overex- 
pression of a BAG-l dominant negative, lacking the C-terminal BAG domain, which is 
critical for the interaction with the 70 kDa heat shock proteins HSC70 and HSP70, failed 
to ameliorate myocyte apoptosrs induced by simulated I/R. Conclusions. We conclude, 
therefore, that BAG-l is a cardioprotective protein and that I/R induces BAG-l intracellu- 
lar relocatron. Furthermore, protection is dependent upon association with HSC70. 
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1146-106 Management and Outcomes of Patients With Acute 
Coronary Syndromes and Gastrointestinal Bleeding 
Mouaz H. AIMallah, Rasha Bazari. Michelle Jankowski, Michael P. Hudson, Henry Ford 
Heart and Vascular Institute, Detroit, Ml 
Background: Potent antiplatelet/ antithrombin agents along with early revascularization 
are increasingly used in patients hospitalized with acute coronary syndromes (ACS). An 
important adverse event associated with these therapies is gastrointestinal bleeding 
(GIB): yet, the optimal management and outcomes related to GIB in ACS patients are 
poorly studied. 
Purpose/ Methods: We retrospectively analyzed the diagnostic studies, pathological/ 
clinical findings and survival associated with GIB in patients hospitalized with ACS at a 
Endoscopy N (%) 30 (36.5%) 
Gastritis N(%) 7 (9%) 
Peptic ulcer disease N(%) 7 (9%) 
Polyps N%) 6 (7.7%) 
Neoplasm N(%) 6 (7.7%) 
Divediculosis N(%) 4 (5.1%) 
AVM N(%) 1 (1.3%) 
Mallory Weiss Tear N(%) 1(1.3%) 
Esophagitis N(%) 1 (1.3%) 
Conclusion: GIB is a rare complication following ACS associated with eightfold higher 
in-hosptial mortality. Endoscopy may be safely performed during the ACS hospitalization 
and confirms diagnosis of GI malignancy in7.7% of patients. 
1146-107 Major Bleeding Incidence After Coronary Artery Bypass 
Grafting in Patients With Unstable Angina/Non-ST 
Elevation Myocardial Infarction Based on Coronary 
Artery Bypass Graft Timing in TACTICS-TIMI- 
Sattsh Bhadhraiu Anthony C. DeFranco, Kim Barber, Sabina A. Murphy, C. Michael 
Gibson, Peter M. DiBattiste, Christopher P. Cannon, McLaren Regronal Medical Center 
and Research Foundation, Flint, MI. Brigham &Women’s Hospital, Harvard Medical 
School, Boston, MA 
Background: Observational studies report ah association between major bleeding rates 
after coronary artery bypass grafting (CABG) and timing of antithrombotic therapy peri- 
CABG. In 1 non-randomized study, pts having CABG <5d of the last dose of clopidogrel 
had a 2-10 fold higher major bleeding rate compared to pts not receiving it. In contrast, a 
comparison of similar pts in the CURE trial found higher transfusion rate and no differ- 
ence in TIMI major bleeding post CABG. We hypothesized that the difference in bleed- 
Log seen in observational studies (and attributed to only 1 factor, clopidogrel ) might be 
explained by other factors such as pt characteristics, CABG timing, and other treatments. 
Methods In TACTICS-TIMI 16, 2220 pts with unstable angina/non-ST MI (UANSTEMI) 
were treated with aspirin, heparin and tirofiban for 46 hours (clopidogrel reserved for 
post-stent in all but 5 patients). We evaluated associations of major bleeding and stroke 
in relation to CABG timing. Results:Factors related to increased bleeding in addition to 
those below, were: history of diabetes, MI, aspirin, PCI, CABG, stable angina, PVD, and 
current troponin T. ST deviation, and 3VD. 
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30.day post-CABG death, MI, or stroke rates did not differ among groups, but there 
was a significantly higher rate of major bleeding in pts sent for CABG<M 
(PcO.001). By multivariate analysis, major bleed risk in CABG<Sd remained higher 
after “correcting” for baselinedifferences(OR=4.4, 95% ci-1.6-12.1 ,P=O.O04). 
Conclusion: 1)ln UAfNSTEMI, CABG performed <5d has 4 fold major bleeding rate 
compared to CABG performed .5d P)Major bleedrng is also dependent oh disease 
severity, antithrombotic therapy, other procedures 3)Caution is required in interpreting 
observational studies that attribute associations (eg higher bleeding) to any 1 factor. 
